The number and State-wise details of medical device manufacturing sites licensed in the country, including in the State of Maharashtra, during the last five years, are given in the Annex.

 

The Government has made wide-ranging efforts to promote the medical device industry in the country, including through provision of financial assistance for the setting up of medical device industry. These efforts include the following:

1. Production Linked Incentive (PLI) scheme for promoting domestic manufacturing of Medical Devices: This scheme has a budgetary outlay of ₹3,420 crore and a five-year performance-linked incentive period from FY2022-23 to FY2026-27. Under the scheme, selected companies are eligible for financial incentive for incremental sales of domestically manufactured medical devices in the radiotherapy, imaging device, anaesthesia, cardio-respiratory and critical care and implant device segments, for a period of five years. As of September 2025, 22 greenfield projects have been commissioned and production has started for 55 products, which include high-end medical devices on which the country has been highly import-dependent, such as linear accelerators, machines for MRI and CT scans and mammograms, C-arm X-ray machines, MRI coils and ultrasound machines. Till September 2025, cumulative eligible sales of ₹12,344.37 crore have been made under the scheme, including export sales worth ₹5,869.36 crore.
2. Scheme for Promotion of Medical Devices Parks: The scheme aims to provide easy access to world-class, common infrastructure facilities to medical device units set up in medical device parks. Under this scheme, three parks have been approved and are at an advanced stage of development in Greater Noida (Uttar Pradesh), Ujjain (Madhya Pradesh) and Kanchipuram (Tamil Nadu) districts. The total project cost of these is ₹871.11 crore, with Central assistance to the tune of ₹100 crore each for creation of common infrastructure facilities, which is expected to enhance industry’s competitiveness and reduce production costs through optimisation of resources and economies of scale. As of November 2025, out of a total of ₹300 crore for the three parks, a total of ₹180 crore stood released. Civil construction for the three parks is at the final stages. As of September 2025, 194 medical devices manufacturers have been allotted land in the three parks in a 298.58 acre area and 34 units have commenced construction of their plants.
3. Scheme for Strengthening Medical Device Industry: This scheme has been launched on 8.11.2024 with a financial outlay of ₹500 crore. It aims to strengthen the medical device industry by providing support in critical areas, including manufacturing of key components and accessories, skill development, support for clinical studies, development of common infrastructure, and industry promotion and consists of the following sub-schemes:

1. Common Facilities for Medical Devices Clusters;
2. Marginal Investment Scheme for Reducing Import Dependence;
3. Capacity Building and Skill Development for Medical Devices;
4. Medical Device Clinical Studies Support Scheme; and
5. Medical Device Promotion Scheme.

This information was given by Union Minister of State in the Ministry of Chemicals and Fertilizers, Smt. Anupriya Patel, in a written reply in Lok Sabha today.

******

 

 

Annexure

 

Annexure referred to in the reply to parts (a) and (d) of the LOK SABHA UNSTARRED Q. NO. 964 for answer on 5.12.2025, regarding Medical Devices Industries

 

Number and State-wise details of medical device manufacturing sites licensed in the country, including in the State of Maharashtra, during the last five years

 

 

*****

PC/GS/SG

(रिलीज़ आईडी: 2199433) आगंतुक पटल : 284